Glucagon-Like Peptide 1 Receptor Agonist in Diabetes Mellitus Management in Children and Adolescents With Transfusion-Dependent Thalassemia

Exclusion Criteria

• •1. Other hemoglobinopathies as alpha thalassemia or sickle thalassemia patients.
• •2. Other disorders that may affect glucose homeostasis rather than β-TM.
• •3. Autoimmune disease, collagen diseases, hypo- or hyper-thyroidism, infections, tumors, hematological diseases other than β-TM.
• •4. Personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN 2).
• •5. Intake of any vitamins or food supplements one month before study and participation in a previous investigational drug study within the three months preceding screening.